These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 19427681)

  • 1. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
    Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
    Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
    Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
    Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive outcome after discharge of patients with high-risk hydatidiform mole with or without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during the uterine evacuation of molar pregnancy.
    Uberti EM; Fajardo Mdo C; Ferreira SV; Pereira MV; Seger RC; Moreira MA; Torres MD; de Nápoli G; Schmid H
    Gynecol Oncol; 2009 Dec; 115(3):476-81. PubMed ID: 19818481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic actinomycin D for high-risk complete hydatidiform mole.
    Limpongsanurak S
    J Reprod Med; 2001 Feb; 46(2):110-6. PubMed ID: 11255809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
    Wang Q; Fu J; Hu L; Fang F; Xie L; Chen H; He F; Wu T; Lawrie TA
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD007289. PubMed ID: 28892119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW; Cho H; Kim H; Nam EJ; Kim SW; Kim S; Kim YT; Kim JH
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of gestational trophoblastic neoplasia with 5-fluorouracil and actinomycin D in northern China.
    Zhao Y; Zhang W; Duan W
    J Reprod Med; 2009 Feb; 54(2):88-94. PubMed ID: 19301571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of postmolar gestational trophoblastic disease with methotrexate and folinic acid: 15 years of experience.
    Sekharan PK; Sreedevi NS; Radhadevi VP; Beegam R; Raghavan J; Guhan B
    J Reprod Med; 2006 Oct; 51(10):835-40. PubMed ID: 17086813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic chemotherapy for hydatidiform mole to prevent gestational trophoblastic neoplasia.
    Fu J; Fang F; Xie L; Chen H; He F; Wu T; Hu L; Lawrie TA
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD007289. PubMed ID: 23076934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia.
    Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS
    Gynecol Oncol; 2009 Feb; 112(2):353-7. PubMed ID: 19059633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial sampling in patients with trophoblastic disease after suction curettage.
    Lertkhachonsuk R; Treratanachat S
    J Reprod Med; 2008 Aug; 53(8):634-8. PubMed ID: 18773630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of prophylactic chemotherapy outcome and clinical characteristics in patients of high-risk hydatidiform mole].
    Geng S; Feng FZ; Xiang Y; Wan XR; Zhou Y
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):24-7. PubMed ID: 21429430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine General Hospital: treatment outcomes and toxicity.
    Cagayan MS; Gacoba MC
    J Reprod Med; 2006 Nov; 51(11):907-18. PubMed ID: 17165439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of high-risk hydatidiform mole and persistent gestational trophoblastic neoplasia: the Korean experience.
    Kim SJ; Na YJ; Jung SG; Kim CJ; Bae SN; Lee C
    J Reprod Med; 2007 Sep; 52(9):819-30. PubMed ID: 17939600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia.
    Liu Y; Ye Y; Cheng X; Lu W; Xie X; Wang X; Li X
    BMC Womens Health; 2023 Jan; 23(1):1. PubMed ID: 36593459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
    Lurain JR; Chapman-Davis E; Hoekstra AV; Schink JC
    J Reprod Med; 2012; 57(7-8):283-7. PubMed ID: 22838241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia.
    Chen LM; Lengyel ER; Bethan Powell C
    Gynecol Oncol; 2004 Jul; 94(1):204-7. PubMed ID: 15262143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia.
    Feng HC; Tsao SW; Ngan HY; Xue WC; Kwan HS; Siu MK; Liao XY; Wong E; Cheung AN
    Histopathology; 2008 Jan; 52(2):167-74. PubMed ID: 18184265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.